Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 5:14 PM
Ignite Modification Date:
2025-12-25 @ 2:51 PM
NCT ID:
NCT00910650
Group ID:
EG000
Title:
F5 TCR Transgenic Cells
Description:
F5 TCR transgenic cell adoptive transfer therapy
F5 TCR transgenic cells and MART-1 peptide pulsed dendritic cells: After chemotherapy, patients receive up to 1 x 10(9) MART-1 F5 TCR transgenic T cells infused i.v., 1 x 10(7) MART-1 peptide pulsed dendritic cells intradermally, and low dose IL-2 500,000 IU/m2 s.c. twice daily for 14 days.
non-myeloablative conditioning chemotherapy: Patients receive non-myeloablative conditioning chemotherapy with Cyclophosphamide 60 mg/kg/day x 2 days and Fludarabine 25 mg/m2/day i.v. over 30 minutes for 4 days
Deaths Number Affected:
14
Deaths Number At Risk:
None
Serious Number Affected:
5
Serious Number At Risk:
14
Other Number Affected:
14
Other Number At Risk:
14
Study:
NCT00910650
Results Section:
NCT00910650
Adverse Events Module:
NCT00910650